Clevudine
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Clevudine (INN) is an antiviral drug for the treatment of hepatitis B (HBV). It is already approved for HBV in South Korea and the Philippines. It is marketed by Bukwang Pharmaceuticals in South Korea under the tradenames Levovir and Revovir. Researchers in South Korea are testing clevudine at lower doses in combination with adefovir for continued use. It is a nucleoside analog.
Clevudine (INN) is an antiviral drug for the treatment of hepatitis B (HBV). It is already approved for HBV in South Korea and the Philippines. It is marketed by Bukwang Pharmaceuticals in South Korea under the tradenames Levovir and Revovir. Researchers in South Korea are testing clevudine at lower doses in combination with adefovir for continued use. It is a nucleoside analog.
References
Text derived from https://en.wikipedia.org/w/index.php?oldid=1346943217 under CC BY-SA 4.0; modifications have been made.